These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11815776)

  • 1. Thalidomide therapy for recalcitrant systemic onset juvenile rheumatoid arthritis.
    Lehman TJ; Striegel KH; Onel KB
    J Pediatr; 2002 Jan; 140(1):125-7. PubMed ID: 11815776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study.
    Lehman TJ; Schechter SJ; Sundel RP; Oliveira SK; Huttenlocher A; Onel KB
    J Pediatr; 2004 Dec; 145(6):856-7. PubMed ID: 15580219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of juvenile rheumatoid arthritis].
    Bardare M; Corona F; Rognoni MG
    Minerva Pediatr; 1992 May; 44(5):211-21. PubMed ID: 1377772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with etanercept for patients with juvenile rheumatoid arthritis in Taiwan--a preliminary report.
    Liang TC; Yang YH; Lin YT; Chiang BL
    J Microbiol Immunol Infect; 2005 Dec; 38(6):447-50. PubMed ID: 16341347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.
    Kimura Y; Pinho P; Walco G; Higgins G; Hummell D; Szer I; Henrickson M; Watcher S; Reiff A
    J Rheumatol; 2005 May; 32(5):935-42. PubMed ID: 15868633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
    Quartier P; Taupin P; Bourdeaut F; Lemelle I; Pillet P; Bost M; Sibilia J; Koné-Paut I; Gandon-Laloum S; LeBideau M; Bader-Meunier B; Mouy R; Debré M; Landais P; Prieur AM
    Arthritis Rheum; 2003 Apr; 48(4):1093-101. PubMed ID: 12687553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of thalidomide for treatment of juvenile idiopathic arthritis].
    Han TX; Li CF; Wang J; Kuang WY; Zhou YF
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Aug; 13(8):631-4. PubMed ID: 21849111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept therapy in children with juvenile rheumatoid arthritis.
    Hung JJ; Huang JL
    J Microbiol Immunol Infect; 2005 Dec; 38(6):444-6. PubMed ID: 16341346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile idiopathic arthritis: an update on clinical and therapeutic approaches.
    Quarta L; Corrado A; Melillo N; Cantatore FP
    Ann Ital Med Int; 2005; 20(4):211-7. PubMed ID: 16610252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of juvenile arthritis.
    Fink CW
    Clin Orthop Relat Res; 1990 Oct; (259):60-9. PubMed ID: 2208875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow-acting antirheumatic drug use in systemic onset juvenile chronic arthritis.
    Manners PJ; Ansell BM
    Pediatrics; 1986 Jan; 77(1):99-103. PubMed ID: 3940364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The place of corticosteroid therapy in juvenile chronic arthritis in 1992.
    Prieur AM
    J Rheumatol Suppl; 1993 Apr; 37():32-4. PubMed ID: 8501749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis.
    Yokota S; Miyamae T; Imagawa T; Iwata N; Katakura S; Mori M; Woo P; Nishimoto N; Yoshizaki K; Kishimoto T
    Arthritis Rheum; 2005 Mar; 52(3):818-25. PubMed ID: 15751095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of medications used in juvenile rheumatoid arthritis.
    Guthrie B; Rouster-Stevens KA; Reynolds SL
    Pediatr Emerg Care; 2007 Jan; 23(1):38-46. PubMed ID: 17228221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid myopathy in a child with juvenile rheumatoid arthritis. Case report.
    Genel F; Arslanoglu S; Hizarcioglu M; Durmaz B; Uran N; Aktaş S
    Panminerva Med; 2003 Mar; 45(1):75-7. PubMed ID: 12682624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis.
    Ramanan AV; Schneider R
    J Rheumatol; 2003 Feb; 30(2):401-3. PubMed ID: 12563702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of thalidomide in systemic onset juvenile rheumatoid arthritis.
    García-Carrasco M; Fuentes-Alexandro S; Escárcega RO; Rojas-Rodriguez J; Escobar LE
    Joint Bone Spine; 2007 Oct; 74(5):500-3. PubMed ID: 17706449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
    Zeft A; Hollister R; LaFleur B; Sampath P; Soep J; McNally B; Kunkel G; Schlesinger M; Bohnsack J
    J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Side effects of anti-TNFalpha therapy in juvenile idiopathic arthritis].
    Pontikaki I; Gerloni V; Gattinara M; Luriati A; Salmaso A; De Marco G; Teruzzi B; Valcamonica E; Fantini F
    Reumatismo; 2006; 58(1):31-8. PubMed ID: 16639486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The toxicity of nonsteroidal antiinflammatory drugs in juvenile rheumatoid arthritis.
    Barron KS; Person DA; Brewer EJ
    J Rheumatol; 1982; 9(1):149-55. PubMed ID: 7086773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.